Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GNMSF | ALNY | BMRN | ||
| Company | Genmab A/S | Alnylam Pharmaceuticals | Biomarin Pharmaceuticals | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 287.0300 | 150.80 | 82.91 | ||
| High | 287.0300 | 153.85 | 85.04 | ||
| Low | 272.9500 | 147.29 | 81.43 | ||
| Last | 276.4700 | 150.31 | 83.76 | ||
| Change | +3.6600 | +0.35 | +0.43 | ||
| % Change | +1.34% | +0.23% | +0.52% | ||
| Volume | 158 | 659,783 | 1,220,026 | ||
| 20-Day Average Volume | 583 | 505,925 | 1,926,005 | ||
| Previous Close | 272.8100 | 149.96 | 83.33 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 284.5319 | 148.09 | 87.75 | ||
| 20-Day Raw Stochastic | 27.33% | 46.10% | 28.93% | ||
| 20-Day Relative Strength | 44.16% | 49.56% | 44.31% | ||
| Weighted Alpha | -31.64 | -28.66 | -12.69 | ||
| Today's Opinion | 100% Sell | 88% Sell | 72% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 72% Sell | ||
| Last Month's Opinion | 56% Sell | 88% Sell | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.45% since 04/25/24 | +4.36% since 04/25/24 | +2.49% since 04/25/24 | ||
| Low | 269.7500 on 04/26/24 | 143.00 on 04/26/24 | 80.50 on 05/01/24 | ||
| High | 288.1500 on 04/26/24 | 153.85 on 05/02/24 | 85.04 on 05/02/24 | ||
| 1-Month | |||||
| %Chg | -7.69% since 04/02/24 | -0.70% since 04/02/24 | -2.97% since 04/02/24 | ||
| Low | 265.3000 on 04/25/24 | 141.98 on 04/25/24 | 80.50 on 05/01/24 | ||
| High | 306.5500 on 04/04/24 | 159.34 on 04/09/24 | 93.36 on 04/15/24 | ||
| 3-Month | |||||
| %Chg | +0.07% since 02/02/24 | -13.34% since 02/02/24 | -4.41% since 02/02/24 | ||
| Low | 262.0000 on 02/13/24 | 141.98 on 04/25/24 | 80.50 on 05/01/24 | ||
| High | 323.0180 on 03/13/24 | 173.33 on 02/06/24 | 94.15 on 02/23/24 | ||
| 6-Month | |||||
| %Chg | -0.16% since 11/02/23 | -7.15% since 11/02/23 | +5.71% since 11/02/23 | ||
| Low | 262.0000 on 02/13/24 | 141.98 on 04/25/24 | 76.19 on 11/06/23 | ||
| High | 334.3280 on 01/08/24 | 199.38 on 01/09/24 | 99.56 on 12/14/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 17,833,590 | 18,886,862 | 15,822,701 | ||
| Shares Outstanding, K | 65,370 | 125,946 | 189,880 | ||
| Annual Sales | 2,392,030,000 | 1,828,290,000 | 2,419,230,000 | ||
| Annual Net Income | 631,910,000 | -440,240,000 | 167,650,000 | ||
| Last Quarter Sales | 674,810,000 | 439,720,000 | 648,830,000 | ||
| Last Quarter Net Income | 90,250,000 | -137,870,000 | 88,660,000 | ||
| 60-Month Beta | 1.05 | 0.41 | 0.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 3.63 on 02/14/24 | -1.10 on 02/15/24 | 0.71 on 04/24/24 | ||
| Latest Earnings Date | 05/08/24 | 05/02/24 | 04/24/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 23.14 | 0.00 | 59.82 | ||